If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 9,155.00
Bid: 9,120.00
Ask: 9,125.00
Change: 135.00 (1.50%)
Spread: 5.00 (0.055%)
Open: 9,040.00
High: 9,180.00
Low: 9,030.00
Prev. Close: 9,020.00
SPX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of US Thermal Energy Specialist

28 Sep 2022 07:00

RNS Number : 9173A
Spirax-Sarco Engineering PLC
28 September 2022
 

 

News Release

 

28th September 2022

Acquisition of US thermal energy specialist

Spirax-Sarco Engineering plc, the thermal energy management and niche pumping specialist, announces that it has entered into a definitive agreement to acquire Durex International Corporation (Durex), a privately-owned US based specialist in custom electric thermal solutions for ultra-high criticality industrial equipment.

 

The consideration is US$342.2 million on a cash and debt free basis, subject to customary closing adjustments. The transaction will be financed through acquisition bank facilities and will be accretive to Group earnings in 2023. Following regulatory approval, completion is expected in October 2022.

 

Durex was founded in 1980 and has close to 380 employees most of whom are located at its headquarters and three manufacturing facilities in Cary, Illinois. In 2021, 89% of its sales were to Original Equipment Manufacturers (OEMs), which tend to be highly recurring in nature. Geographically, 87% of sales were generated in North America and 12% in Asia Pacific, with 60% of total sales to OEMs in the Semiconductor sector.

 

Durex has a strong track record of top line growth and profitability. For the 12 months to 31st August 2022, revenues were US$74.5 million, EBITDA was US$25.3 million and EBIT was US$23.5 million. For the full year ended 31st December 2021, revenues were US$61.7 million, EBITDA was US$18.7 million and EBIT was US$17.1 million.

 

Durex provides OEMs with custom-designed precision thermal solutions with embedded electric heating, cooling and sensing technologies. These high criticality solutions are incorporated by the OEMs into complex equipment requiring precise thermal control, such as Semiconductor Wafer Fabrication Equipment (WFE). Durex is well positioned to capitalise on the growing trend of increasingly stringent thermal demands in high technology equipment and processes. 

 

Upon completion, Durex will form part of the Group's Electric Thermal Solutions Business (ETS) which comprises Chromalox, Thermocoax and shortly Vulcanic. Chromalox and Vulcanic will be the lead brands for electric process heating, including decarbonisation of industrial processes. Thermocoax and Durex will be the lead brands for high criticality OEM applications, are highly complementary with minimal customer overlap and will strengthen coverage of the North American and European markets. Durex will accelerate the development of ETS' critical OEM business in attractive market sectors and target application areas, fulfilling key objectives of ETS' growth strategy. 

 

Nicholas Anderson, Group Chief Executive, Spirax-Sarco Engineering plc, said: "We are excited about this opportunity to further strengthen our ETS Business and look forward to welcoming colleagues from Durex into our Group. We have great respect and admiration for Durex that has grown and developed under the skilful leadership of Ed Hinz, who founded the business over 40 years ago. Ed's impending retirement provided an excellent opportunity for us to broaden our capabilities in key target sectors, accelerating the development of our ETS business in line with our long-term plans."

 

 

Enquiries:

Nicholas Anderson, Group Chief Executive

Andrew Guthrie, Head of Investor Relations

 

About Spirax‐Sarco Engineering plc

Spirax‐Sarco Engineering plc is a thermal energy management and niche pumping specialist. It comprises three world‐leading Businesses: Steam Specialties, for the control and management of steam; Electric Thermal Solutions, for advanced electrical process heating and temperature management solutions; and Watson-Marlow, for peristaltic pumping and associated fluid path technologies. The Steam Specialties and Electric Thermal Solutions Businesses provide a broad range of fluid control and electrical process heating products, engineered packages, site services and systems expertise for a diverse range of industrial and institutional customers. Both Businesses help their end users to improve production efficiency, meet their environmental sustainability targets, improve product quality and enhance the safety of their operations. Watson‐Marlow provides solutions for a wide variety of demanding fluid path applications with highly accurate, controllable and virtually maintenance-free pumps and associated technologies.

 

The Group is headquartered in Cheltenham, UK, has strategically located manufacturing plants around the world and employs more than 9,200 people, including more than 2,000 direct sales and service engineers. The Company's shares have been listed on the London Stock Exchange since 1959 (symbol: SPX) and it is a constituent of the FTSE 100 and the FTSE4Good indices.

 

 

Further information can be found at www.spiraxsarcoengineering.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQBKOBDBBKBPCB
Date   Source Headline
14th Nov 20134:28 pmRNSDirector/PDMR Shareholding
7th Nov 20137:00 amRNSInterim Management Statement
5th Nov 20134:24 pmRNSTotal Voting Rights
11th Oct 20139:08 amRNSDirector/PDMR Shareholding
2nd Oct 20132:00 pmRNSTotal Voting Rights
2nd Oct 20139:48 amRNSNotification of Release Date - IMS
23rd Sep 20138:41 amRNSHolding(s) in Company
3rd Sep 20138:56 amRNSTotal Voting Rights
30th Aug 20138:00 amRNSAcquisition
22nd Aug 20133:56 pmRNSHolding(s) in Company
13th Aug 20134:28 pmRNSDirector/PDMR Shareholding
8th Aug 20137:00 amRNS2013 Half Year Results
7th Aug 201310:00 amRNSBoard Changes
6th Aug 20134:26 pmRNSTotal Voting Rights
12th Jul 20133:20 pmRNSDates for 2013 Half-Year Results
5th Jul 20135:24 pmRNSDirector/PDMR Shareholding
1st Jul 20133:17 pmRNSTotal Voting Rights
24th Jun 20133:34 pmRNSHolding(s) in Company
31st May 20137:00 amRNSAmendment to Official List
22nd May 20139:14 amRNSDirector/PDMR Shareholding
9th May 20134:22 pmRNSResult of AGM
9th May 20137:00 amRNSInterim Management Statement
1st May 20139:42 amRNSTotal Voting Rights
1st May 20138:53 amRNSChange of Director Details
18th Apr 20133:51 pmRNSHolding(s) in Company
12th Apr 20138:48 amRNSDirector/PDMR Shareholding
10th Apr 201311:01 amRNSDirector/PDMR Shareholding Replacement
10th Apr 20138:50 amRNSDirector/PDMR Shareholding
2nd Apr 201312:39 pmRNSTotal Voting Rights
22nd Mar 20139:41 amRNSAnnual Financial Report
19th Mar 20133:28 pmRNSDirector/PDMR Shareholding
13th Mar 20137:00 amRNSDirector/PDMR Shareholding
7th Mar 20137:00 amRNSFinal Results 2012
6th Mar 20132:03 pmRNSTotal Voting Rights
26th Feb 20133:30 pmRNSDirector Declaration
5th Feb 20139:37 amRNSTotal Voting Rights
2nd Jan 20133:54 pmRNS2013 Key Dates
2nd Jan 20133:54 pmRNSTotal Voting Rights
2nd Jan 20133:54 pmRNSDirector/PDMR Shareholding
21st Dec 20125:21 pmRNSDirector/PDMR Shareholding
14th Dec 20129:07 amRNSDirector/PDMR Shareholding
6th Dec 20122:58 pmRNSDirector/PDMR Shareholding
3rd Dec 20124:03 pmRNSTotal Voting Rights
15th Nov 20128:25 amRNSHolding(s) in Company
8th Nov 20123:52 pmRNSHolding(s) in Company
7th Nov 20129:30 amRNSAcquisition
7th Nov 20127:00 amRNSInterim Management Statement
2nd Nov 20122:16 pmRNSTotal Voting Rights
23rd Oct 20123:19 pmRNSHolding(s) in Company
18th Oct 20124:36 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.